Literature DB >> 28090710

Fibrillatory wave amplitude on transesophageal ECG as a marker of left atrial low-voltage areas in patients with persistent atrial fibrillation.

Ran Yin1, Yongnan Fu1, Zhongming Yang1, Bingong Li1, Jintian Pen1, Zeqi Zheng1.   

Abstract

BACKGROUND: Low-voltage areas (LVAs) are frequently observed in patients with persistent atrial fibrillation (PeAF) and may represent adverse atrial remodeling. However, noninvasive method of evaluating LAVs is not well established.
METHODS: In a cohort of 68 patients with PeAF, endocardial voltage maps of left atrium (LA) were created during sinus rhythm after pulmonary vein isolation (PVI). LVAs were defined as areas with electrogram amplitudes <0.5 mV. LA-LVAs were correlated with clinical, echocardiographic, surface, and transesophageal electrocardiography (TE-ECG) variables.
RESULTS: LA voltage mapping revealed any degree of LA-LVAs in 50 (73.5%) patients. Patients with LA-LVAs were older, had a longer history of AF, and lower fibrillatory wave (F wave) amplitude on TE-ECG (0.27 ± 0.06 vs 0.39 ± 0.08 mv, p < .01) as compared to patients without LA-LVAs. The extent of LA-LVAs was weakly correlated with age (R = 0.36, p = .03) and AF duration (R = 0.26, p = .02), but significantly correlated with F-wave amplitude on TE-ECG (R = -0.57, p < .01). Only F-wave amplitude on TE-ECG was found as independent predictor for the presence of LA-LVAs (OR = 1.53, 95% CI = 1.09-2.96, p = .03). A receiver operating characteristic (ROC) curve identified an F-wave amplitude of 0.29 mV (AUC = 0.788; sensitivity = 68.4%; specificity = 73.2%) on TE-ECG as the optimal cutoff value for predicting LA-LVAs.
CONCLUSIONS: As a noninvasive investigation, F-wave amplitude on TE-ECG may be used as an indicator for the presence of LA-LVAs.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial arrhythmias; clinical; electrocardiography; electrophysiology; noninvasive techniques

Mesh:

Year:  2017        PMID: 28090710      PMCID: PMC6931520          DOI: 10.1111/anec.12421

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  18 in total

1.  Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation.

Authors:  Andrew W Teh; Peter M Kistler; Geoffrey Lee; Caroline Medi; Patrick M Heck; Steven J Spence; Joseph B Morton; Prashanthan Sanders; Jonathan M Kalman
Journal:  Heart Rhythm       Date:  2011-11-10       Impact factor: 6.343

2.  Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation.

Authors:  Sascha Rolf; Simon Kircher; Arash Arya; Charlotte Eitel; Philipp Sommer; Sergio Richter; Thomas Gaspar; Andreas Bollmann; David Altmann; Carlos Piedra; Gerhard Hindricks; Christopher Piorkowski
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08-23

3.  Esophageal pacing: a diagnostic and therapeutic tool.

Authors:  J J Gallagher; W M Smith; C R Kerr; J Kasell; L Cook; M Reiter; R Sterba; M Harte
Journal:  Circulation       Date:  1982-02       Impact factor: 29.690

4.  Comparison of frequency of thromboembolic events and echocardiographic findings in patients with chronic nonvalvular atrial fibrillation and coarse versus fine electrocardiographic fibrillatory waves.

Authors:  Satoshi Yamamoto; Michihiro Suwa; Takahide Ito; Shougo Murakami; Tatsuya Umeda; Yasunobu Tokaji; Yasuhiko Sakai; Yasushi Kitaura
Journal:  Am J Cardiol       Date:  2005-08-01       Impact factor: 2.778

5.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

6.  Electrophysiology and endocardial mapping of induced atrial fibrillation in patients with spontaneous atrial fibrillation.

Authors:  S Saksena; I Giorgberidze; R Mehra; M Hill; A Prakash; R B Krol; P Mathew
Journal:  Am J Cardiol       Date:  1999-01-15       Impact factor: 2.778

7.  Associations among the CHADS(2) score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation.

Authors:  Tze-Fan Chao; Chen-Chuan Cheng; Wei-Shiang Lin; Hsuan-Ming Tsao; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Kazuyoshi Suenari; Cheng-Hung Li; Shuen-Hsin Liu; Beny Hartono; Tsu-Juey Wu; Shih-Ann Chen
Journal:  Heart Rhythm       Date:  2011-03-12       Impact factor: 6.343

8.  Left atrial appendage flow in nonrheumatic atrial fibrillation : relationship with pulmonary venous flow and ECG fibrillatory wave amplitude.

Authors:  A Bollmann; K Binias; F Grothues; K Sonne; H Esperer; P Nikutta; H Klein
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

9.  Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation.

Authors:  Isabelle Nault; Nicolas Lellouche; Seiichiro Matsuo; Sébastien Knecht; Matthew Wright; Kang-Teng Lim; Frederic Sacher; Pyotr Platonov; Antoine Deplagne; Pierre Bordachar; Nicolas Derval; Mark D O'Neill; George J Klein; Mélèze Hocini; Pierre Jaïs; Jacques Clémenty; Michel Haïssaguerre
Journal:  J Interv Card Electrophysiol       Date:  2009-04-30       Impact factor: 1.900

10.  A novel individualized substrate modification approach for the treatment of long-standing persistent atrial fibrillation: preliminary results.

Authors:  Xin-Hua Wang; Zheng Li; Jia-Liang Mao; Ben He
Journal:  Int J Cardiol       Date:  2014-05-15       Impact factor: 4.164

View more
  3 in total

1.  Fibrillatory wave amplitude on transesophageal ECG as a marker of left atrial low-voltage areas in patients with persistent atrial fibrillation.

Authors:  Ran Yin; Yongnan Fu; Zhongming Yang; Bingong Li; Jintian Pen; Zeqi Zheng
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-01-16       Impact factor: 1.468

2.  Multi-scale Entropy Evaluates the Proarrhythmic Condition of Persistent Atrial Fibrillation Patients Predicting Early Failure of Electrical Cardioversion.

Authors:  Eva María Cirugeda Roldan; Sofía Calero; Víctor Manuel Hidalgo; José Enero; José Joaquín Rieta; Raúl Alcaraz
Journal:  Entropy (Basel)       Date:  2020-07-07       Impact factor: 2.524

3.  Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry.

Authors:  Tetsuma Kawaji; Hisashi Ogawa; Yasuhiro Hamatani; Masashi Kato; Takafumi Yokomatsu; Shinji Miki; Mitsuru Abe; Masaharu Akao
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.